The Sharing of T Cell Clones in Peripheral CD8+PD-1+T Cells with TILs is a Novel Biomarker Predicting the Efficacy of Anti -PD-L1 Therapy
Journal of clinical oncology(2018)
摘要
e15007Background: The optimal biomarker to select suitable patients for immune checkpoint blockades (ICBs) therapy remains to be well established. The dynamic variations of molecular alterations du...
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要